US Stock MarketDetailed Quotes

Reviva Pharmaceuticals (RVPH)

Watchlist
  • 0.3615
  • +0.0111+3.17%
Trading Jan 16 14:16 ET
42.24MMarket Cap-0.82P/E (TTM)

Reviva Pharmaceuticals (RVPH) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
137.16%13.18M
67.75%10.36M
-55.82%5.29M
-42.33%13.48M
-42.33%13.48M
11.80%5.56M
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
-Cash and cash equivalents
137.16%13.18M
67.75%10.36M
-55.82%5.29M
-42.33%13.48M
-42.33%13.48M
11.80%5.56M
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
Prepaid assets
-91.17%81.74K
-80.25%104.45K
-72.83%211.86K
590.47%540.6K
590.47%540.6K
--925.53K
--528.95K
--779.6K
--78.3K
--78.3K
Other current assets
-23.90%247.93K
-34.02%346.96K
1.71%756.07K
161.72%666.44K
161.72%666.44K
-21.44%325.81K
-23.84%525.83K
-54.84%743.38K
-36.94%254.64K
-36.94%254.64K
Total current assets
98.42%13.51M
49.53%10.82M
-53.64%6.26M
-38.05%14.68M
-38.05%14.68M
26.42%6.81M
-38.92%7.23M
4.61%13.5M
25.24%23.7M
25.24%23.7M
Non current assets
Non current prepaid assets
0.00%819.72K
0.00%819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--819.72K
----
--0
--0
Total non current assets
0.00%819.72K
0.00%819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--819.72K
--0
--0
--0
Total assets
87.85%14.33M
44.48%11.63M
-47.56%7.08M
-34.59%15.5M
-34.59%15.5M
41.63%7.63M
-32.00%8.05M
4.61%13.5M
25.24%23.7M
25.24%23.7M
Liabilities
Current liabilities
Payables
-38.12%5.43M
5.87%4.97M
-17.47%4.72M
63.24%6.28M
63.24%6.28M
66.29%8.78M
77.22%4.69M
99.98%5.72M
9.34%3.85M
9.34%3.85M
-accounts payable
-38.12%5.43M
5.87%4.97M
-17.47%4.72M
63.24%6.28M
63.24%6.28M
66.29%8.78M
77.22%4.69M
99.98%5.72M
9.34%3.85M
9.34%3.85M
Current accrued expenses
-54.80%3.52M
-17.48%6.39M
-16.84%6.01M
-41.59%7.22M
-41.59%7.22M
3.44%7.79M
22.24%7.75M
138.22%7.22M
110.43%12.37M
110.43%12.37M
Current debt and capital lease obligation
----
-45.42%113.25K
-32.44%224.3K
--458.15K
--458.15K
-62.70%83K
-6.74%207.5K
-50.26%332K
----
----
-Current debt
----
-45.42%113.25K
-32.44%224.3K
--458.15K
--458.15K
-62.70%83K
-6.74%207.5K
-50.26%332K
----
----
Current liabilities
-44.46%9.74M
-13.39%12.08M
-20.58%11.51M
-14.98%14.6M
-14.98%14.6M
34.53%17.53M
51.43%13.94M
120.91%14.49M
72.41%17.18M
72.41%17.18M
Non current liabilities
Derivative product liabilities
-42.86%44.51K
-88.89%16.69K
-92.06%27.82K
-88.97%89.01K
-88.97%89.01K
-91.08%77.88K
-85.16%150.21K
-37.00%350.48K
42.16%806.66K
42.16%806.66K
Total non current liabilities
-42.86%44.51K
-88.89%16.69K
-92.06%27.82K
-88.97%89.01K
-88.97%89.01K
-91.08%77.88K
-85.16%150.21K
-37.00%350.48K
42.16%806.66K
42.16%806.66K
Total liabilities
-44.45%9.78M
-14.19%12.09M
-22.27%11.54M
-18.30%14.69M
-18.30%14.69M
26.64%17.61M
37.90%14.09M
108.56%14.84M
70.78%17.98M
70.78%17.98M
Shareholders'equity
Share capital
187.62%9.62K
128.03%6.8K
67.41%4.67K
66.83%4.66K
66.83%4.66K
47.64%3.34K
31.66%2.98K
36.53%2.79K
36.53%2.79K
36.53%2.79K
-common stock
187.62%9.62K
128.03%6.8K
67.41%4.67K
66.83%4.66K
66.83%4.66K
47.64%3.34K
31.66%2.98K
36.53%2.79K
36.53%2.79K
36.53%2.79K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-14.40%-180.77M
-18.12%-176.76M
-20.40%-170.71M
-22.27%-164.27M
-22.27%-164.27M
-30.91%-158.01M
-35.78%-149.65M
-45.02%-141.79M
-41.29%-134.35M
-41.29%-134.35M
Paid-in capital
25.19%185.31M
22.76%176.29M
18.37%166.24M
17.86%165.08M
17.86%165.08M
31.95%148.03M
28.41%143.6M
35.62%140.44M
35.35%140.07M
35.35%140.07M
Total stockholders'equity
145.58%4.55M
92.40%-459.15K
-231.40%-4.46M
-85.79%812.57K
-85.79%812.57K
-17.17%-9.98M
-472.66%-6.04M
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
Total equity
145.58%4.55M
92.40%-459.15K
-231.40%-4.46M
-85.79%812.57K
-85.79%812.57K
-17.17%-9.98M
-472.66%-6.04M
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 137.16%13.18M67.75%10.36M-55.82%5.29M-42.33%13.48M-42.33%13.48M11.80%5.56M-44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M
-Cash and cash equivalents 137.16%13.18M67.75%10.36M-55.82%5.29M-42.33%13.48M-42.33%13.48M11.80%5.56M-44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M
Prepaid assets -91.17%81.74K-80.25%104.45K-72.83%211.86K590.47%540.6K590.47%540.6K--925.53K--528.95K--779.6K--78.3K--78.3K
Other current assets -23.90%247.93K-34.02%346.96K1.71%756.07K161.72%666.44K161.72%666.44K-21.44%325.81K-23.84%525.83K-54.84%743.38K-36.94%254.64K-36.94%254.64K
Total current assets 98.42%13.51M49.53%10.82M-53.64%6.26M-38.05%14.68M-38.05%14.68M26.42%6.81M-38.92%7.23M4.61%13.5M25.24%23.7M25.24%23.7M
Non current assets
Non current prepaid assets 0.00%819.72K0.00%819.72K--819.72K--819.72K--819.72K--819.72K--819.72K------0--0
Total non current assets 0.00%819.72K0.00%819.72K--819.72K--819.72K--819.72K--819.72K--819.72K--0--0--0
Total assets 87.85%14.33M44.48%11.63M-47.56%7.08M-34.59%15.5M-34.59%15.5M41.63%7.63M-32.00%8.05M4.61%13.5M25.24%23.7M25.24%23.7M
Liabilities
Current liabilities
Payables -38.12%5.43M5.87%4.97M-17.47%4.72M63.24%6.28M63.24%6.28M66.29%8.78M77.22%4.69M99.98%5.72M9.34%3.85M9.34%3.85M
-accounts payable -38.12%5.43M5.87%4.97M-17.47%4.72M63.24%6.28M63.24%6.28M66.29%8.78M77.22%4.69M99.98%5.72M9.34%3.85M9.34%3.85M
Current accrued expenses -54.80%3.52M-17.48%6.39M-16.84%6.01M-41.59%7.22M-41.59%7.22M3.44%7.79M22.24%7.75M138.22%7.22M110.43%12.37M110.43%12.37M
Current debt and capital lease obligation -----45.42%113.25K-32.44%224.3K--458.15K--458.15K-62.70%83K-6.74%207.5K-50.26%332K--------
-Current debt -----45.42%113.25K-32.44%224.3K--458.15K--458.15K-62.70%83K-6.74%207.5K-50.26%332K--------
Current liabilities -44.46%9.74M-13.39%12.08M-20.58%11.51M-14.98%14.6M-14.98%14.6M34.53%17.53M51.43%13.94M120.91%14.49M72.41%17.18M72.41%17.18M
Non current liabilities
Derivative product liabilities -42.86%44.51K-88.89%16.69K-92.06%27.82K-88.97%89.01K-88.97%89.01K-91.08%77.88K-85.16%150.21K-37.00%350.48K42.16%806.66K42.16%806.66K
Total non current liabilities -42.86%44.51K-88.89%16.69K-92.06%27.82K-88.97%89.01K-88.97%89.01K-91.08%77.88K-85.16%150.21K-37.00%350.48K42.16%806.66K42.16%806.66K
Total liabilities -44.45%9.78M-14.19%12.09M-22.27%11.54M-18.30%14.69M-18.30%14.69M26.64%17.61M37.90%14.09M108.56%14.84M70.78%17.98M70.78%17.98M
Shareholders'equity
Share capital 187.62%9.62K128.03%6.8K67.41%4.67K66.83%4.66K66.83%4.66K47.64%3.34K31.66%2.98K36.53%2.79K36.53%2.79K36.53%2.79K
-common stock 187.62%9.62K128.03%6.8K67.41%4.67K66.83%4.66K66.83%4.66K47.64%3.34K31.66%2.98K36.53%2.79K36.53%2.79K36.53%2.79K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -14.40%-180.77M-18.12%-176.76M-20.40%-170.71M-22.27%-164.27M-22.27%-164.27M-30.91%-158.01M-35.78%-149.65M-45.02%-141.79M-41.29%-134.35M-41.29%-134.35M
Paid-in capital 25.19%185.31M22.76%176.29M18.37%166.24M17.86%165.08M17.86%165.08M31.95%148.03M28.41%143.6M35.62%140.44M35.35%140.07M35.35%140.07M
Total stockholders'equity 145.58%4.55M92.40%-459.15K-231.40%-4.46M-85.79%812.57K-85.79%812.57K-17.17%-9.98M-472.66%-6.04M-123.26%-1.35M-31.87%5.72M-31.87%5.72M
Total equity 145.58%4.55M92.40%-459.15K-231.40%-4.46M-85.79%812.57K-85.79%812.57K-17.17%-9.98M-472.66%-6.04M-123.26%-1.35M-31.87%5.72M-31.87%5.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More